Discover groundbreaking insights on lupus nephritis treatment from the REGENCY trial, highlighting the impact of obintuzumab on patient outcomes.
Shikha Wadhwani, MD, MS
Advertisement
Articles by Shikha Wadhwani, MD, MS
Advertisement
Latest Updated Articles
Kidney Compass: Obinutuzumab, REGENCY, & Updates in Lupus Nephritis, With Brad Rovin, MDPublished: November 8th 2025 | Updated:
Advertisement
Advertisement